Bivin & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.09M Sell
6,162
-872
-12% -$155K 1.18% 16
2022
Q1
$1.25M Sell
7,034
-412
-6% -$70.1K 1.14% 16
2021
Q4
$1.27M Buy
+7,446
New +$1.22M 1.11% 17

Other funds holding JNJ

Bivin & Associates's JNJ Position: Q2 2022 in Review

Bivin & Associates reduced its Johnson & Johnson (JNJ) stake by 12% in Q2 2022, selling an estimated $155K and leaving 6,162 shares worth $1.09M. The position accounts for 1.18% of the portfolio, ranked #16.

Bivin & Associates first reported a position in JNJ in Q4 2021 and has held it in 3 quarters since. The position peaked at $1.27M in Q4 2021. 3,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.

  • Bivin & Associates held 6,162 shares of Johnson & Johnson worth $1.09M as of Q2 2022.
  • Bivin & Associates sold 872 Johnson & Johnson shares in Q2 2022, an estimated $155K.
  • Johnson & Johnson made up 1.18% of Bivin & Associates's portfolio in Q2 2022, its #16 holding.
  • Bivin & Associates first reported a position in Johnson & Johnson in Q4 2021 and has held it in 3 quarters since.
  • Bivin & Associates's Johnson & Johnson position peaked at $1.27M in Q4 2021.
  • 3,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.